Skip to main content

OrbiMed Advisors LLC

SEC CIK
0001055951
Latest filing
Aug 14, 2026

RLMD holding history

Relmada Therapeutics, Inc. in every 13F filed by OrbiMed Advisors LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

RLMD overviewAll 13F holders of RLMDFull Q2 2026 holdings

Shares (Q2 2026)
3,631,195
Value
$25.1M
% of portfolio
0.5%
Quarters held
3
Since Q4 2025
Holdings of RLMD by OrbiMed Advisors LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20263,631,195$25.1M0.5%−1,084,669−23.0%ReducedHolders
Q1 20264,715,864$32.8M0.7%+2,105,264+80.6%AddedHolders
Q4 20252,610,600$12.6M0.3%+2,610,600NewHolders